Products found to contain undeclared medicines
|
| |
| Singapore: Retail-level recall of IMPACTRA due to detection of sildenafil, tadalafil and chloropretadalafil |
| |
The Health Sciences Authority (HSA) announces that Gold Tree Pte Ltd is recalling all batches of health supplements IMPACTRA from the retail level. The product was tested under HSA’s product quality surveillance programme and was found to contain prohibited substances sildenafil, tadalafil and chloropretadalafil. Retail suppliers should stop selling all batches of IMPACTRA.
Please refer to the following website in HSA for details:
http://www.hsa.gov.sg/announcements/product-recall/impactra
In Hong Kong, the above product is not a registered pharmaceutical product
Ends/ Saturday, Feb 15, 2020
Issued at HKT 12:00
|
| |
